ISSN: 2530-0164

Indexed in:

Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.8

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.474

View more metrics

Journal Information

Congress

Congress content

Congress

XXXIII Congreso de la Sociedad Española de Diabetes

Las Palmas De Gran Canaria , 27 - 29 April 2022

List of sessions

Descargar el PDF completo del suplemento

XXXIII Congreso de la Sociedad Española de Diabetes

List of sessions

Descargar el PDF completo del suplemento

Session

Session information

3. SESIÓN ORAL 03: EXPERIMENTAL, GENÉTICA E INMUNOLOGÍA

DATE: 27-APR-22

TYPE: COMUNICACIONES ORALES

Communications

CO-013 EL TRATAMIENTO CON miRNAs EXOSOMALES INDUCE UNA MEJORA METABÓLICA SIMILAR AL EJERCICIO EN RATONES OBESOS

C. Castaño Pérez, A. Novials Sardà y M. Párrizas JiménezIdibaps, Barcelona.

CO-014 INTRACELLULAR PRODUCTION OF HYDROGEN SULFIDE IS REQUIRED FOR THE ACCUMULATION OF LIPIDS IN HEPATOCYTES AND ADIPOCYTES

A. Martín-Montalvo Sánchez^a,b, M. Cáliz-Molina^a, A. Sola-García^a, D. González-Morán^a, C. Panadero-Morón^a, I. Pino-Pérez^a and I. Espadas-Villanueva^a^aCabimer, Sevilla, Spain. ^bCIBERDEM, Sevilla, Spain.

CO-015 STEM CELL DERIVED FUNCTIONAL BETA CELLS TO MODEL DIABETES CAUSED BY GENETIC DEFECTS IN THE REGULATORY GENOME

D. Balboa^a,b, A. Beucher^c, I. Miguel-Escalada^a,b, A. Bernal^a,b, E. Bernardo^a,b, M. Cuenca-Ardura^a,b and J. Ferrer^a,b,c^aCentro de Regulación Genómica, Barcelona, Spain. ^bCIBER de Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, Spain. ^cSection of Genomics and Genetics, Department of Medicine, and National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, Imperial College London, London, United Kingdom.

CO-016 UN LNCRNA ASOCIADO A DIABETES TIPO 1 (LNC-RINABCIN) PARTICIPA EN LA INFLAMACIÓN DE LA CÉLULA BETA PANCREÁTICA MEDIANTE LA REGULACIÓN DE GENES ASOCIADOS CON LA RESPUESTA ANTIVIRAL

I. González Moro^a,b, K. García Etxebarria^c, L. Mendoza^a y I. Santín Gómez^a,b,d

^aUniversidad Del Pais Vasco, Leioa. ^bIIS Biocruces Bizkaia, Barakaldo. ^cIIS Biodonostia, Donostia. ^dCIBERDEM.

CO-017 GENOME-WIDE CRISPR SCREENS IDENTIFY THERAPEUTIC TARGETS FOR HNF1A-DEFICIENT DIABETES

M. Cuenca-Ardura^a, M. De Vas^b and J. Ferrer^a,b^aCentre for Genomic Regulation (CRG), Barcelona, Spain. ^bImperial College London, London, United Kingdom.

CO-018 HNF1A REGULATES AN ALTERNATIVE SPLICING PROGRAM IN PANCREATIC BETA CELLS

E. Bernardo^a,c, D. Balboa^a,c, M. De Vas^b, M. Cuenca Ardura^a,c, M. Maestro^a,c, A. Bernal^a,c and J. Ferrer^a,b,c^aCentro de Regulación Genómica, Barcelona, Spain. ^bSection of Genomics and Genetics, Department of Medicine, and National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, Imperial College of London, London, United Kingdom, ^cCIBER de Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, Spain.